120 related articles for article (PubMed ID: 6256890)
1. [Septicemia due to polyresistant Staphylococcus aureus (author's transl)].
Bonnardot JP; Bonvoisin R; Bryskier A
Sem Hop; 1980 Nov 18-25; 56(43-44):1850-2. PubMed ID: 6256890
[TBL] [Abstract][Full Text] [Related]
2. [Vancomycin in staphylococcus septicemia (author's transl)].
González MA; Arteaga A
Rev Med Chil; 1974 Jul; 102(7):532-5. PubMed ID: 4471392
[No Abstract] [Full Text] [Related]
3. Chromatographically purified vancomycin: therapy of serious infections caused by Staphylococcus aureus and other gram-positive bacteria.
Wang LS; Liu CY; Wang FD; Fung CP; Chiu ZH; Cheng DL
Clin Ther; 1988; 10(5):574-84. PubMed ID: 2856600
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcal sepsis in patients on chronic hemodialysis regimens: intravenous treatment with vancomycin given once weekly.
Barcenas CG; Fuller TJ; Elms J; Cohen R; White MG
Arch Intern Med; 1976 Oct; 136(10):1131-4. PubMed ID: 971012
[TBL] [Abstract][Full Text] [Related]
5. [Use of vancomycin in the treatment of severe Staphylococcus aureus infection. Description of 3 cases].
Campelli A; Mantero E; Fabbri A; Nahum M; Ferraris R; Di Noto C
Minerva Med; 1984 Feb; 75(8):385-90. PubMed ID: 6709217
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of severe infections and septicemia caused by S. aureus (author's transl)].
Coppens L
Rev Med Brux; 1982 Jun; 3(6):403-8. PubMed ID: 6921830
[No Abstract] [Full Text] [Related]
7. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
[TBL] [Abstract][Full Text] [Related]
8. [Effect of inhaled vancomycin hydrochloride on elimination of methicillin-resistant Staphylococcus aureus].
Shirai M; Ide K; Sato M; Murakami M; Tanaka Y; Sato A; Chida K
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1233-9. PubMed ID: 8583715
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
Kitzis MD; Goldstein FW
Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin therapy in severe staphylococcal infections.
Kirby WM
Rev Infect Dis; 1981; 3 suppl():S236-9. PubMed ID: 7342287
[TBL] [Abstract][Full Text] [Related]
11. [Fatal septicemia from Staphylococcus aureus resistance to glycopeptides].
Villevieille T; Vincenti-Rouquette I; Koeck JL; Petitjeans F; Rousseau JM; Brinquin L
Ann Fr Anesth Reanim; 2001 May; 20(5):498-9. PubMed ID: 11419246
[No Abstract] [Full Text] [Related]
12. Pharmacology and efficacy of vancomycin for staphylococcal infections in children.
Schaad UB; Nelson JD; McCracken GH
Rev Infect Dis; 1981; 3 suppl():S282-8. PubMed ID: 7342292
[TBL] [Abstract][Full Text] [Related]
13. Limitations of vancomycin in the management of resistant staphylococcal infections.
Kollef MH
Clin Infect Dis; 2007 Sep; 45 Suppl 3():S191-5. PubMed ID: 17712746
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Aug; 46(33):765-6. PubMed ID: 9272582
[TBL] [Abstract][Full Text] [Related]
15. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
Giacometti A; Cirioni O; Ghiselli R; Dell'Acqua G; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Rocchi M; Balaban N; Saba V; Scalise G
Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527
[TBL] [Abstract][Full Text] [Related]
16. Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(27):624-6. PubMed ID: 9218648
[TBL] [Abstract][Full Text] [Related]
17. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia.
Masur H; Francioli P; Ruddy M; Murray HW
Clin Nephrol; 1983 Aug; 20(2):85-8. PubMed ID: 6616979
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
20. Methicillin resistant Staphylococcus aureus.
Salaria M; Singh M
Indian Pediatr; 2001 Jan; 38(1):29-36. PubMed ID: 11175931
[No Abstract] [Full Text] [Related]
[Next] [New Search]
